Literature DB >> 30051750

Amyloid Plaques of Alzheimer's Disease as Hotspots of Glutamatergic Activity.

Saak V Ovsepian1,2,3, Valerie B O'Leary3, Laszlo Zaborszky4, Vasilis Ntziachristos1,2, J Oliver Dolly3.   

Abstract

Deposition of amyloid plaques in limbic and associative cortices is amongst the most recognized histopathologic hallmarks of Alzheimer's disease. Despite decades of research, there is a lack of consensus over the impact of plaques on neuronal function, with their role in cognitive decline and memory loss undecided. Evidence has emerged suggesting complex and localized axonal pathology around amyloid plaques, with a significant fraction of swellings and dystrophies becoming enriched with putative synaptic vesicles and presynaptic proteins normally colocalized at hotspots of transmitter release. In the absence of hallmark active zone proteins and postsynaptic receptive elements, the axonal swellings surrounding amyloid plaques have been suggested as sites for ectopic release of glutamate, which under reduced clearance can lead to elevated local excitatory drive. Throughout this review, we consider the emerging data suggestive of amyloid plaques as hotspots of compulsive glutamatergic activity. Evidence for local and long-range effects of nonsynaptic glutamate is discussed in the context of circuit dysfunctions and neurodegenerative changes of Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease; axonal dystrophies; ectopic release; glutamate; metabotropic receptors; paracrine signaling

Year:  2018        PMID: 30051750      PMCID: PMC6348130          DOI: 10.1177/1073858418791128

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  58 in total

Review 1.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Authors:  Byron Caughey; Peter T Lansbury
Journal:  Annu Rev Neurosci       Date:  2003-04-09       Impact factor: 12.449

2.  Differential control of synaptic and ectopic vesicular release of glutamate.

Authors:  Ko Matsui; Craig E Jahr
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

3.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

Authors:  John R Cirrito; Kelvin A Yamada; Mary Beth Finn; Robert S Sloviter; Kelly R Bales; Patrick C May; Darryle D Schoepp; Steven M Paul; Steven Mennerick; David M Holtzman
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

4.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

5.  Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease.

Authors:  M Kawai; P Cras; P Richey; M Tabaton; D E Lowery; P A Gonzalez-DeWhitt; B D Greenberg; P Gambetti; G Perry
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

6.  Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.

Authors:  José Luis Albasanz; Esther Dalfó; Isidro Ferrer; Mairena Martín
Journal:  Neurobiol Dis       Date:  2005-06-08       Impact factor: 5.996

7.  Extracellular potassium rapidly inhibits axonal transport of particles in cultured mouse dorsal root ganglion neurites.

Authors:  H Hiruma; S Nishida; T Katakura; T Kusakabe; T Takenaka; T Kawakami
Journal:  J Neurobiol       Date:  1999-02-05

8.  Three-dimensional structures of canine senile plaques.

Authors:  K Miyawaki; H Nakayama; S Nakamura; K Uchida; K Doi
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

9.  In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.

Authors:  John R Cirrito; Patrick C May; Mark A O'Dell; Jennie W Taylor; Maia Parsadanian; Jeffrey W Cramer; James E Audia; Jeffrey S Nissen; Kelly R Bales; Steven M Paul; Ronald B DeMattos; David M Holtzman
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

10.  Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms.

Authors:  Hiromi Hiruma; Takashi Katakura; Sanae Takahashi; Takafumi Ichikawa; Tadashi Kawakami
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

View more
  15 in total

1.  LY379268 Does Not Have Long-Term Procognitive Effects nor Attenuate Glutamatergic Signaling in AβPP/PS1 Mice.

Authors:  Kevin N Hascup; Jesse Britz; Caleigh A Findley; Shelley Tischkau; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.

Authors:  Alexey M Petrov; Morrie Lam; Natalia Mast; Jean Moon; Yong Li; Erin Maxfield; Irina A Pikuleva
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

3.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

Review 4.  Astroglia in Alzheimer's Disease.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Jose Julio Rodriguez-Arellano; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease Progression.

Authors:  Caleigh A Findley; Andrzej Bartke; Kevin N Hascup; Erin R Hascup
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

Review 6.  Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease.

Authors:  Lenka Hromadkova; Saak Victor Ovsepian
Journal:  J Immunol Res       Date:  2019-08-06       Impact factor: 4.818

7.  In Vivo Plasticity at Hippocampal Schaffer Collateral-CA1 Synapses: Replicability of the LTP Response and Pharmacology in the Long-Evans Rat.

Authors:  A Ahnaou; E White; R Biermans; N V Manyakov; W H I M Drinkenburg
Journal:  Neural Plast       Date:  2020-11-12       Impact factor: 3.599

Review 8.  Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.

Authors:  Viera Kútna; Valerie B O'Leary; Ehren Newman; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2021-01-04       Impact factor: 7.620

Review 9.  Dendritic spine remodeling and plasticity under general anesthesia.

Authors:  Simon Granak; Cyril Hoschl; Saak V Ovsepian
Journal:  Brain Struct Funct       Date:  2021-06-01       Impact factor: 3.270

10.  BRUCE silencing leads to axonal dystrophy by repressing autophagosome-lysosome fusion in Alzheimer's disease.

Authors:  Lu Zhang; Yu Fang; Xinyu Zhao; Yake Zheng; Yunqing Ma; Shuang Li; Zhi Huang; Lihao Li
Journal:  Transl Psychiatry       Date:  2021-08-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.